HIV

/Tag:HIV

SAHIVSoc publishes Clinical Guidelines for HIV Self-Testing

Written by John Kelly, CEO at Atomo Diagnostics: The Southern African HIV Clinicians Society (SAHIVSoc) has recently published it's clinical guidelines for HIV self-testing to support achieving the first '90' of [...]

June 19th, 2017|

Atomo Diagnostics’ HIV Self Test receives approval from Kenya Ministry of Health

Sydney, Australia, May 30, 2017| Multi-award winning medical device innovator Atomo Diagnostics today announced its pioneering HIV self test product has been approved for sale in Kenya. Following successful product [...]

May 30th, 2017|

Canadian Government Fund Invests in Atomo

Delighted to welcome new investors for 2017, earlier this month Atomo Diagnostics announced backing from Grand Challenges Canada (GCC). Investment from the Canadian Government-funded agency totalling US$1 million (A$1.31 million, [...]

February 20th, 2017|

Atomo Diagnostics receives further international financing

SYDNEY, Australia, 1 February  2017: Medical device innovator Atomo Diagnostics today announced it had received US$1 million (A$1.31 million, C$1.32 million) in financing from Grand Challenges Canada to support its continued [...]

February 1st, 2017|

AtomoRapid featured in latest issue of Australian Biochemist

The December issue of Australian Biochemist is out and Atomo Diagnostics is highlighted in its Special Technical Feature on microfluidics and molecular diagnostic technologies that have revolutionised testing for infectious [...]

December 23rd, 2016|

Atomo creates a buzz at Medica 2016

Written by John Kelly, CEO at Atomo Diagnostics: Medica is one of those events that I look forward to every year, and my team and I have been coming here [...]

November 15th, 2016|